• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两个芳香族残基调节人类催产素受体对部分激动剂精氨酸加压素的反应。

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.

作者信息

Chini B, Mouillac B, Balestre M N, Trumpp-Kallmeyer S, Hoflack J, Hibert M, Andriolo M, Pupier S, Jard S, Barberis C

机构信息

CNR Cellular and Molecular Pharmacology Center, Milan, Italy.

出版信息

FEBS Lett. 1996 Nov 18;397(2-3):201-6. doi: 10.1016/s0014-5793(96)01135-0.

DOI:10.1016/s0014-5793(96)01135-0
PMID:8955347
Abstract

We investigated the mechanisms that regulate the efficacy of agonists in the arginine-vasopressin (AVP)/oxytocin (OT) receptor system. In this paper, we present evidence that AVP, a full agonist of the vasopressin receptors, acts as a partial agonist on the oxytocin receptor. We also found that AVP becomes a full agonist when two aromatic residues of the oxytocin receptor are replaced by the residues present at equivalent positions in the vasopressin receptor subtypes. Our results indicate that these two residues modulate the response of the oxytocin receptor to the partial agonist AVP.

摘要

我们研究了调节精氨酸加压素(AVP)/催产素(OT)受体系统中激动剂效力的机制。在本文中,我们提供证据表明,加压素受体的完全激动剂AVP对催产素受体起部分激动剂的作用。我们还发现,当催产素受体的两个芳香族残基被加压素受体亚型中相应位置的残基取代时,AVP就会变成完全激动剂。我们的结果表明,这两个残基调节催产素受体对部分激动剂AVP的反应。

相似文献

1
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.两个芳香族残基调节人类催产素受体对部分激动剂精氨酸加压素的反应。
FEBS Lett. 1996 Nov 18;397(2-3):201-6. doi: 10.1016/s0014-5793(96)01135-0.
2
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.血管加压素/催产素受体家族中激动剂选择性的分子基础。
Adv Exp Med Biol. 1995;395:321-8.
3
Binding domains of the oxytocin receptor for the selective oxytocin receptor antagonist barusiban in comparison to the agonists oxytocin and carbetocin.与激动剂缩宫素和卡贝缩宫素相比,选择性缩宫素受体拮抗剂巴芦米布的缩宫素受体结合结构域。
Eur J Pharmacol. 2005 Mar 7;510(1-2):9-16. doi: 10.1016/j.ejphar.2005.01.010.
4
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regions.神经肽血管加压素V1a受体的结合位点。跨膜区域内主要定位的证据。
J Biol Chem. 1995 Oct 27;270(43):25771-7. doi: 10.1074/jbc.270.43.25771.
5
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.鉴定参与配体结合和G蛋白偶联的神经垂体激素受体结构域。
Adv Exp Med Biol. 1998;449:371-85. doi: 10.1007/978-1-4615-4871-3_48.
6
Molecular cloning and functional characterization of the oxytocin receptor from a rat pancreatic cell line (RINm5F).来自大鼠胰腺细胞系(RINm5F)的催产素受体的分子克隆与功能特性分析
Neuropeptides. 1996 Dec;30(6):557-65. doi: 10.1016/s0143-4179(96)90039-6.
7
Identification of agonist binding sites of vasopressin and oxytocin receptors.
Adv Exp Med Biol. 1995;395:301-10.
8
Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.猪白膜、附睾和输精管中催产素和加压素两类受体的鉴定与表征
Endocrinology. 1987 Mar;120(3):986-94. doi: 10.1210/endo-120-3-986.
9
Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.比较精氨酸加压素和催产素类似物在狨猴、猕猴和人血管加压素 1a 受体中的药理学特性。
Biomed Pharmacother. 2020 Jun;126:110060. doi: 10.1016/j.biopha.2020.110060. Epub 2020 Mar 4.
10
Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor.通过将催产素受体的激动剂和肽拮抗剂结合位点转移至V2加压素受体所确定的这些位点。
J Biol Chem. 1996 Dec 6;271(49):31593-601. doi: 10.1074/jbc.271.49.31593.

引用本文的文献

1
The Oxytocin System and Implications for Oxytocin Deficiency in Hypothalamic-Pituitary Disease.催产素系统及其对下丘脑 - 垂体疾病中催产素缺乏的影响。
Endocr Rev. 2025 Feb 22. doi: 10.1210/endrev/bnaf008.
2
Effects of oxytocin receptor agonists on hair growth promotion.促性腺激素释放激素激动剂对毛发生长的促进作用。
Sci Rep. 2024 Oct 13;14(1):23935. doi: 10.1038/s41598-024-74962-9.
3
Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.靶向催产素受体治疗乳腺癌:肽示踪剂的新领域。
J Med Chem. 2024 Feb 8;67(3):1625-1640. doi: 10.1021/acs.jmedchem.3c01089. Epub 2024 Jan 18.
4
Oxytocin and oxygen: the evolution of a solution to the 'stress of life'.催产素和氧气:解决“生命压力”的解决方案的演变。
Philos Trans R Soc Lond B Biol Sci. 2022 Aug 29;377(1858):20210054. doi: 10.1098/rstb.2021.0054. Epub 2022 Jul 11.
5
Cryo-electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex.抗利尿激素精氨酸加压素V2受体信号复合物的冷冻电子显微镜结构
Sci Adv. 2021 May 21;7(21). doi: 10.1126/sciadv.abg5628. Print 2021 May.
6
Oxytocin Receptor Signaling in Vascular Function and Stroke.血管功能与中风中的催产素受体信号传导
Front Neurosci. 2020 Sep 25;14:574499. doi: 10.3389/fnins.2020.574499. eCollection 2020.
7
The oxytocin receptor signalling system and breast cancer: a critical review.催产素受体信号系统与乳腺癌:批判性回顾。
Oncogene. 2020 Sep;39(37):5917-5932. doi: 10.1038/s41388-020-01415-8. Epub 2020 Aug 11.
8
A Nonpeptide Oxytocin Receptor Agonist for a Durable Relief of Inflammatory Pain.一种非肽类催产素受体激动剂,可持久缓解炎症性疼痛。
Sci Rep. 2020 Feb 20;10(1):3017. doi: 10.1038/s41598-020-59929-w.
9
Revisiting the classification of adhesion GPCRs.重新审视黏附 GPCR 分类。
Ann N Y Acad Sci. 2019 Nov;1456(1):80-95. doi: 10.1111/nyas.14192. Epub 2019 Jul 31.
10
A Comparison of the Ability of Leu- and Pro-Oxytocin to Regulate Intracellular Ca and Ca-Activated K Channels at Human and Marmoset Oxytocin Receptors.人及狨猴催产素受体上 Leu- 和 Pro- 催产素调节细胞内 Ca 和 Ca 激活 K 通道能力的比较。
Mol Pharmacol. 2019 Apr;95(4):376-385. doi: 10.1124/mol.118.114744. Epub 2019 Feb 9.